TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial.

Ruben A Mesa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.